Government Control

Opinion

Opinion: Price Controls Hurt Cancer Patients, Risk Future Innovation – Inside Sources

The U.S. Senate just announced legislation within Medicare Part D with the headline “lower prescription drug costs for beneficiaries living with cancer.” Behind this headline, with a further examination of this proposal, there are caution lights and red flags raised by cancer survivors like myself and patient-focused healthcare organizations. The problem is the government price

Opinion

Opinion: Potentials for Bitcoin in State Government – Inside Sources

Our country is dealing with some of the highest inflation in a generation while COVID jitters and government restrictions shake the economy. But state and local policymakers are not powerless to protect their residents. There is always Bitcoin. In a time of inflation, ballooning government debts, and broader financial uncertainty, a Bitcoin-first policy would be a welcome

Scroll to Top